| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |